All Terrain Financial Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

All Terrain Financial Advisors, LLC

  • $261 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$574.03 - $680.96 $238,222 - $282,598
-415 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$472.8 - $558.54 $196,212 - $231,794
415 New
415 $232,000
Q1 2021

May 13, 2021
SELL
$446.73 - $548.2 $185,392 - $227,503
-415 Closed
0 $0
Q4 2020

Feb 08, 2021
BUY
$478.3 - $607.98 $198,494 - $252,311
415 New
415 $200,000

Others Institutions Holding REGN

# of Institutions
1,509
Shares Held
82.7M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $72.9B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track All Terrain Financial Advisors, LLC Portfolio

Follow All Terrain Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of All Terrain Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on All Terrain Financial Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email